Drug nanocrystals: in vivo performances.

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Long-Circulating and Target-Specific Nanoparticles: Theory to Practice

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521 · see citing works

Nanoparticles in cancer therapy and diagnosis

Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,040 · see citing works

Nanomedicine: current status and future prospects

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · see citing works

Nanosuspensions in drug delivery

Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,528 · see citing works

Targeted drug delivery via the folate receptor

Sudimack, J. J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,477 · see citing works

Nanosuspensions as particulate drug formulations in therapy

Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370 · see citing works

Inhaling medicines: delivering drugs to the body through the lungs

Patton, J. S., & Byron, P. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,329 · see citing works

Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach

des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305 · see citing works

Nanosizing: a formulation approach for poorly-water-soluble compounds

Merisko-Liversidge, E. M., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,259 · see citing works

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

Labiris, N. R., & DOLOVICH, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,250 · see citing works

The basics and underlying mechanisms of mucoadhesion

SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation

KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061 · see citing works

Nanosizing — Oral formulation development and biopharmaceutical evaluation

Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,058 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

Nanocrystal technology, drug delivery and clinical applications

Müller, R. H., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 954 · see citing works

Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

Desai, M. P., Labhasetwar, V. D., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941 · see citing works

Targeting nanoparticles to cancer

Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 928 · see citing works

Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles

Müller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 822 · see citing works

Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 741 · see citing works

Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products

Eerdenbrugh, B. V., den Mooter, G. V., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 719 · see citing works

Inhaled nanoparticles—A current review

Yang, W. P., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 670 · see citing works

Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics

Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625 · see citing works

Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology

Merisko-Liversidge, E. M., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608 · see citing works

Recent Perspectives in Ocular Drug Delivery

Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600 · see citing works

In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs

Dressman, J., & Reppas, C. I. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00181-0 · Cited by 580 · see citing works

Nanotechnology in ocular drug delivery

Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 554 · see citing works

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works

The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs

Kipp, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 530 · see citing works

Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs

Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 509 · see citing works

Nanosuspensions for the Formulation of Poorly Soluble Drugs

Müller, R. H., Jacobs, C., & Kayser, O. (2000) · Drugs and the pharmaceutical sciences · doi:10.1201/b14005-13 · Cited by 502 · see citing works

Nanotechnological advances for the delivery of cns therapeutics.

Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488 · see citing works

Nanomedicine in pulmonary delivery

Mansour, H. M., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 486 · see citing works

Nanosuspensions for the formulation of poorly soluble drugs

Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 481 · see citing works

Polymeric nanoparticulate system: A potential approach for ocular drug delivery

Nagarwal, R. C., Kant, S., Singh, P., Maiti, P., & Pandit, J. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.018 · Cited by 481 · see citing works

Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration

Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439 · see citing works

Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)

Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 427 · see citing works

Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system

Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 421 · see citing works

Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods

Peltonen, L., & Hirvonen, J. J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01022.x · Cited by 407 · see citing works

Surface functionalized alumina nanoparticle filled polymeric nanocomposites with enhanced mechanical properties

Guo, Z., Pereira, T., Choi, O., Wang, Y., & Hahn, H. T. (2006) · Journal of Materials Chemistry · doi:10.1039/b603020c · Cited by 390 · see citing works

Characterization of folate-chitosan-DNA nanoparticles for gene therapy

Mansouri, S., Yan, C., Winnik, F. M., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, É., & Fernandes, J. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.09.020 · Cited by 389 · see citing works

Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs

Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120030422 · Cited by 388 · see citing works

Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery

Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367 · see citing works

Nanotechnology in Ocular Drug Delivery

Patel, D. H., Pathak, D., & Giradkar, P. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_18 · Cited by 362 · see citing works

Targeted drug delivery via folate receptors

Zhao, X. B., Li, H., & Lee, R. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.309 · Cited by 358 · see citing works

The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems

Kayser, O., Lemke, A., & Hernández-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 350 · see citing works

Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen

Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350 · see citing works

Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals

Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304 · see citing works

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns

Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299 · see citing works

Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats

Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294 · see citing works

Cell-based drug delivery

Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 292 · see citing works

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 284 · see citing works

Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs

Kassem, M. A. A., ABDELRAHMAN, A., Ghorab, M., Ahmed, M. F. E., & Khalil, R. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279 · see citing works

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

Wu, Y., Loper, A. E., Landis, E., Hettrick, L. A., Novak, L. B., Lynn, K., Chen, C. S., Thompson, K. C., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275 · see citing works

Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling

Ali, H. S. M., York, P., Ali, A. M. A., & Blagden, N. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.007 · Cited by 253 · see citing works

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Dou, H., Destache, C. J., Morehead, J., Mosley, R. L., Boska, M. D., Kingsley, J. D., Gorantla, S., Poluektova, L. Y., Nelson, J. A., Chaubal, M. V., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253 · see citing works

Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies

Shenoy, D. B., Little, S. R., Langer, R., & Amiji, M. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8343-0 · Cited by 246 · see citing works

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246 · see citing works

Therapeutic potential of nanoparticulate systems for macrophage targeting

Chellat, F., Merhi, Y., Moreau, A., & Yahia, L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.044 · Cited by 237 · see citing works

Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection

Peters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 230 · see citing works

Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting

Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221 · see citing works

Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study

Chaubal, M. V., & Popescu, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9625-0 · Cited by 216 · see citing works

Formation, characterization, and fate of inhaled drug nanoparticles

Zhang, J., Wu, L., Chan, H., & Watanabe, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.002 · Cited by 210 · see citing works

Preparation of a chemically stable quercetin formulation using nanosuspension technology

Gao, L., Liu, G., Wang, X., Liu, F., Xu, Y., & Ma, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.009 · Cited by 204 · see citing works

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug☆

Hanafy, A., Spahn-Langguth, H., Vergnault, G., Grenier, P., Tubić-Grozdanis, M., Lenhardt, T., & Langguth, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.005 · Cited by 203 · see citing works

Evaluation of nano- and microparticle uptake by the gastrointestinal tract

Delié, F. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00041-6 · Cited by 202 · see citing works

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

Drew, R. H., Ashley, E. D., Benjamin, D. K., Davis, R. D., Palmer, S. M., & Perfect, J. R. (2004) · Transplantation · doi:10.1097/01.tp.0000101516.08327.a9 · Cited by 198 · see citing works

Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196 · see citing works

Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract

Ponchel, G., Montisci, M., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191 · see citing works

Formulation of amphotericin B as nanosuspension for oral administration

Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 187 · see citing works

Enhanced drug dissolution using evaporative precipitation into aqueous solution

Sarkari, M., Brown, J., Chen, X., Swinnea, S., Williams, R. O., & Johnston, K. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00072-8 · Cited by 187 · see citing works

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

Andes, D., Marchillo, K., Conklin, R., Krishna, G., Ezzet, F., Cacciapuoti, A., & Loebenberg, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.137-142.2004 · Cited by 177 · see citing works

Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications

Dodou, D., Breedveld, P., & Wieringa, P. A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.007 · Cited by 175 · see citing works

In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis

Andes, D. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1179-1186.2003 · Cited by 170 · see citing works

Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application

Agnihotri, S. M., & Vavia, P. R. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.07.003 · Cited by 164 · see citing works

Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability

Cerdeira, A. M., Mazzotti, M., & Gander, B. A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.020 · Cited by 160 · see citing works

Targeted Cancer Therapy With Novel High Drug-Loading Nanocrystals

Liu, F., Park, J. Y., Zhang, Y., Conwell, C. C., Liu, Y., Bathula, S. R., & Huang, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22112 · Cited by 159 · see citing works

Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions

Gao, L., Zhang, D., Chen, M., Duan, C., Dai, W., Jia, L., & Zhao, W. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.016 · Cited by 159 · see citing works

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat

Rabinow, B. E., Kipp, J., Papadopoulos, P., Wong, J., Glosson, J., Gass, J. H., Sun, C.-S., Wielgos, T., White, R., Cook, C. S., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.030 · Cited by 153 · see citing works

SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX IN LUNG TRANSPLANT RECIPIENTS12

Palmer, S. M., Drew, R. H., Whitehouse, J. D., Tapson, V. F., Davis, R. D., McConnell, R. R., Kanj, S. S., & Perfect, J. R. (2001) · Transplantation · doi:10.1097/00007890-200108150-00036 · Cited by 148 · see citing works

Preparation and antitumor study of camptothecin nanocrystals

Zhang, H., Hollis, C. P., Zhang, Q., & Li, T. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.075 · Cited by 146 · see citing works

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

Omid Veiseh, A., Kievit, F. M., Ellenbogen, R. G., & Zhang, M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.010 · Cited by 146 · see citing works

Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis

Ye, J., Wang, Q., Zhou, X., & Zhang, N. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.014 · Cited by 134 · see citing works

Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells

Zhang, L., Hou, S., Mao, S., Wei, D., Song, X., & Lü, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.015 · Cited by 134 · see citing works

Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats

Yang, W. P., Johnston, K. P., & Williams, R. O. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.01.011 · Cited by 134 · see citing works

Use of Nanoparticles for Cerebral Cancer

Kreuter, J., & Gelperina, S. E. (2008) · Tumori Journal · doi:10.1177/030089160809400220 · Cited by 131 · see citing works

Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility

Mou, D., Chen, H., Wan, J., Xu, H., & Yang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.034 · Cited by 131 · see citing works

Bioengineering of Therapeutic Aerosols

Edwards, D. A., & Dunbar, C. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.100101.132311 · Cited by 125 · see citing works

Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer

Gao, Y., Li, Z., Sun, M. H., Li, H., Guo, C., Cui, J., Li, A., Cao, F., Xi, Y., Lou, H., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003695139 · Cited by 124 · see citing works

Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery

Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.022 · Cited by 122 · see citing works

Nanoparticles: Characteristics, Mechanisms of Action, and Toxicity in Pulmonary Drug Delivery—A Review

Gill, S., Löbenberg, R., Ku, T., Azarmi, S., Roa, W., & Prenner, E. J. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.015 · Cited by 118 · see citing works

Erythrocyte-based drug delivery

Rossi, L., Serafini, S., Pierigè, F., Antonelli, A., Cerasi, A., Fraternale, A., Chiarantini, L., & Magnani, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.311 · Cited by 116 · see citing works

Diclofenac nanosuspensions: Influence of preparation procedure and crystal form on drug dissolution behaviour

Lai, F., Sinico, C., Ennas, G., Marongiu, F., Marongiu, G., & Fadda, A. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.024 · Cited by 112 · see citing works

High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers

Yang, W. P., Tam, J. M., Miller, D. A., Zhou, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.003 · Cited by 111 · see citing works

Preparation and characterization of intravenously injectable curcumin nanosuspension

Gao, Y., Li, Z., Sun, M. H., Guo, C., Yu, A., Xi, Y., Cui, J., Lou, H., & Zhai, G. (2010) · Drug Delivery · doi:10.3109/10717544.2010.520353 · Cited by 111 · see citing works

Preparation and characterization of intravenously injectable nimodipine nanosuspension

Xiong, R., Lu, W., Li, J., Wang, P., Xu, R., & Chen, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.036 · Cited by 108 · see citing works

Pharmacodynamics and pharmacokinetics of budesonide: A new nebulized corticosteroid

Szefler, S. J. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70059-x · Cited by 107 · see citing works

Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism

Huang, J., Si, L., Jiang, L., Fan, Z., Qiu, J., & Gao, L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.028 · Cited by 106 · see citing works

Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches

Fakes, M. G., Vakkalagadda, B. J., Qian, F., Desikan, S., Gandhi, R. B., Lai, C. J., Hsieh, A., Franchini, M. K., Toale, H., & Brown, J. L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.018 · Cited by 105 · see citing works

Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908

Müller, R. H., & Wallis, K. H. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90304-x · Cited by 105 · see citing works

Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation

Shegokar, R., & Singh, K. K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.041 · Cited by 103 · see citing works

Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets

Lai, F., Pini, E., Angioni, G., Manca, M. L., Perricci, J., Sinico, C., & Fadda, A. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.005 · Cited by 103 · see citing works

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Vergnault, G., & Spahn-Langguth, H. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-52182 · Cited by 98 · see citing works

Nanoparticles: A personal experience for formulating poorly water soluble drugs

Cooper, E. R. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.006 · Cited by 92 · see citing works

The effects of excipients on transporter mediated absorption

Goole, J., Lindley, D. J., Roth, W. J., Carl, S. M., Amighi, K., Kauffmann, J., & Knipp, G. T. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.019 · Cited by 91 · see citing works

Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound

Ain-Ai, A., & GUPTA, P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.029 · Cited by 86 · see citing works

Bioadhesion of solid oral dosage forms, why and how?

Duchêne, D., & Ponchel, G. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00097-0 · Cited by 85 · see citing works

Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats

Li, X., Gu, L., Xu, Y., & Wang, Y. (2009) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802623941 · Cited by 85 · see citing works

Single dose and multiple dose studies of itraconazole nanoparticles

Vaughn, J. M., McConville, J. T., Burgess, D., Peters, J. I., Johnston, K. P., Talbert, R. L., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.006 · Cited by 85 · see citing works

Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs

Pu, X., Sun, J., Li, M., & He, Z. (2009) · Current Nanoscience · doi:10.2174/157341309789378177 · Cited by 85 · see citing works

Nanoparticles in Drug Delivery: Potential Green Nanobiomedicine Applications

Ravichandran, R. (2009) · doi:10.1080/19430850903430427 · Cited by 75 · see citing works

Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development

Sigfridsson, K., Lundqvist, A. J., & Strimfors, M. (2009) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903025855 · Cited by 73 · see citing works

Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation

Sauron, R. É., Wilkins, M. R., Jessent, V., Dubois, A., Maillot, C., & Weil, A. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44064 · Cited by 72 · see citing works

A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications

Kayser, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00640-2 · Cited by 71 · see citing works

To PEGylate or not to PEGylate, that is not the question

Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.025 · Cited by 69 · see citing works

Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs

Böhm, B. H. L., & Müller, R. H. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00177-7 · Cited by 67 · see citing works

A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound

Sigfridsson, K., Forssén, S., den Hollander, P. H. C., Skantze, U., & de Verdier, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.02.008 · Cited by 67 · see citing works

Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery

Gorantla, S., Dou, H., Boska, M. D., Destache, C. J., Nelson, J., Poluektova, L. Y., Rabinow, B. E., Gendelman, H. E., & Mosley, R. L. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206110 · Cited by 67 · see citing works

In vitro and in vivo antitumor activity of oridonin nanosuspension

Lou, H., Zhang, X., Gao, L., Feng, F., Wang, J.-Y., Wei, X., Yu, Z., Zhang, D., & Zhang, Q. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.022 · Cited by 67 · see citing works

SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood–brain barriers

Shubar, H. M., Lachenmaier, S., Heimesaat, M. M., Lohman, U., Mauludın, R., Mueller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2010) · Journal of drug targeting · doi:10.3109/10611861003733995 · Cited by 66 · see citing works

Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS

Wempe, M. F., Wright, C., Little, J. L., Lightner, J., Large, S. E., Caflisch, G. B., Buchanan, C. M., Rice, P. J., Wacher, V. J., & Ruble, K. M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.021 · Cited by 64 · see citing works

The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers

Kraft, W. K., Steiger, B. W., Beussink, D., Quiring, J. N., Fitzgerald, N., Greenberg, H. E., & Waldman, S. A. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003261490 · Cited by 62 · see citing works

Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells

Lamprecht, A., Koenig, P., Ubrich, N., Maincent, P., & Neumann, D. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/15/009 · Cited by 59 · see citing works

Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice

Lou, H., Gao, L., Wei, X., Zhang, Z., Zheng, D., Zhang, D., Zhang, X., Li, Y., & Zhang, Q. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.037 · Cited by 58 · see citing works

Relative Bioavailability and Effects of a High Fat Meal on Single Dose Cilostazol Pharmacokinetics

Bramer, S. L., & Forbes, W. P. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937002-00002 · Cited by 58 · see citing works

Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery

Chiang, P., Alsup, J. W., Lai, Y., Hu, Y., Heyde, B. R., & Tung, D. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-008-9234-1 · Cited by 58 · see citing works

The Physiologic Effects of Inhaled Amphotericin B

DuBois, J. M., Bartter, T. C., Gryn, J., & Pratter, M. R. (1995) · CHEST Journal · doi:10.1378/chest.108.3.750 · Cited by 56 · see citing works

Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas

Lemke, A., Kiderlen, A. F., Petri, B., & Kayser, O. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.004 · Cited by 55 · see citing works

Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice

Zirar, S. B., Astier, A., Muchow, M., & Gibaud, S. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.012 · Cited by 50 · see citing works

In vitro Inhibition of Fungal Activity by Macrophage‐Mediated Sequestration and Release of Encapsulated Amphotericin B Nanosupension in Red Blood Cells

Staedtke, V., Brähler, M., Müller, A., Georgieva, R. T., Bauer, S., Sternberg, N., Voigt, A., Lemke, A., Keck, C. M., Möschwitzer, J. P., et al. (2009) · Small · doi:10.1002/smll.200900919 · Cited by 49 · see citing works

Physical Stability of Ethyl Diatrizoate Nanocrystalline Suspension in Steam Sterilization

Na, G. C., Stevens, J., Yuan, B. O., & Rajagopalan, N. (1999) · Pharmaceutical Research · doi:10.1023/a:1018883431970 · Cited by 48 · see citing works

Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote

Ali, R., Jain, G. K., Iqbal, Z., Talegaonkar, S., Pandit, P., Sule, S., Malhotra, G., Khar, R. K., Bhatnagar, A., & Ahmad, F. J. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.07.001 · Cited by 48 · see citing works

Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization.

Yasukawa, T., Kimura, H., Tabata, Y., Miyamoto, H., Honda, Y., Ikada, Y., & Ogura, Y. (1999) · PubMed · Cited by 47 · see citing works

Polyethylene Glycol as a Solvent for Diazepam: Bioavailability and Clinical Effects after Intramuscular Administration, Comparison of Oral, Intramuscular and Rectal Administration, and Precipitation from Intravenous Solutions

Korttila, K. T., Sothman, A., & Andcrsson, P. (1976) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1976.tb03161.x · Cited by 47 · see citing works

In Vivo Efficacy of Aerosolized Nanostructured ItraconazoleFormulations for Prevention of Invasive Pulmonary Aspergillosis

Hoeben, B. J., Burgess, D. S., McConville, J. T., Najvar, L. K., Talbert, R. L., Peters, J. I., Wiederhold, N. P., Frei, B. L., Graybill, J. R., Bocanegra, R. A., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1552-1554.2006 · Cited by 46 · see citing works

Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives

Grama, C. N., Ankola, D. D., & Kumar, M. N. V. R. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.11.005 · Cited by 44 · see citing works

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis

Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.014 · Cited by 43 · see citing works

Oral Delivery of 1,3‐Dicyclohexylurea Nanosuspension Enhances Exposure and Lowers Blood Pressure in Hypertensive Rats

Ghosh, S., Chiang, P., Wahlstrom, J. L., Fujiwara, H., Selbo, J. G., & Roberds, S. L. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00213.x · Cited by 42 · see citing works

In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen

Vergote, G. J., Vervaet, C., Driessche, I. V., Hoste, S., Smedt, S. C. D., Demeester, J., Jain, R. A., Ruddy, S., & Remon, J. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00114-x · Cited by 42 · see citing works

A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development

Sigfridsson, K., Nordmark, A., Theilig, S., & Lindahl, A. H. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.504209 · Cited by 40 · see citing works

Identification of Peptide Ligands Facilitating Nanoparticle Attachment to Erythrocytes

Hall, S. S., Mitragotri, S., & Daugherty, P. S. (2007) · Biotechnology Progress · doi:10.1021/bp060333l · Cited by 37 · see citing works

Mechanisms of Creatine Kinase Release from Isolated Rat Skeletal Muscles Damaged by Propylene Glycol and Ethanol

Brazeau, G. A., & Fung, H. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790506 · Cited by 36 · see citing works

Experiments on the toxic, sedative and muscle relaxant potency of various drug solvents in mice

Budden, R., Kühl, U. G., & Bahlsen, J. (1979) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(79)90119-0 · Cited by 34 · see citing works

Formulation of a protein with propellant HFA 134a for aerosol delivery

Williams, R. O., & Liu, J. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00015-3 · Cited by 34 · see citing works

Stealth nanoparticles coated with heparin as peptide or protein carriers

Socha, M., Bartecki, P., Passirani, C., Sapin‐Minet, A., Damgé, C., Lecompte, T., Barré, J., El-Ghazouani, F., & Maincent, P. (2009) · Journal of drug targeting · doi:10.1080/10611860903112909 · Cited by 33 · see citing works

Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells

Lotero, L. A., Olmos, G., & Diez, J. C. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00536-6 · Cited by 31 · see citing works

Murine airway histology and intracellular uptake of inhaled amorphous itraconazole

Vaughn, J. M., Wiederhold, N. P., McConville, J. T., Coalson, J. J., Talbert, R. L., Burgess, D. S., Johnston, K. P., Williams, R. O., & Peters, J. I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.014 · Cited by 29 · see citing works

Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma

Shrewsbury, S. B., Bosco, A., & Uster, P. S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.012 · Cited by 29 · see citing works

Polymeric Carrier Systems for siRNA Delivery

Vader, P., van der Aa, L. J., Storm, G., Schiffelers, R. M., & Engbersen, J. F. J. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612798919123 · Cited by 28 · see citing works

Drug Delivery through Phagocytosis of Red Blood Cells

Serafini, S., Rossi, L., Antonelli, A., Fraternale, A., Cerasi, A., Crinelli, R., Chiarantini, L., Schiavano, G. F., & Magnani, M. (2004) · Transfusion Medicine and Hemotherapy · doi:10.1159/000078042 · Cited by 25 · see citing works

Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment

Wahlstrom, J. L., Chiang, P., Ghosh, S., Warren, C. J., Wene, S. P., Albin, L. A., Smith, M. E., & Roberds, S. L. (2007) · Nanoscale Research Letters · doi:10.1007/s11671-007-9063-7 · Cited by 24 · see citing works

Folate-targeted drug-delivery systems prepared by nano-comminution

Kim, S., & Lee, J. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.496788 · Cited by 24 · see citing works

A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance

Salzberg, M. O., Pless, M., Rochlitz, C. F., Ambrus, K., Scigalla, P., & Herrmann, R. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-4061-z · Cited by 12 · see citing works

Pharmaceutical evaluation of a new spacer device for delivery of metered-dose inhalers to infants and young children

Ashurst, I., Ambrose, C. V., & Russell, D. J. (1992) · Journal of Aerosol Science · doi:10.1016/0021-8502(92)90458-8 · Cited by 6 · see citing works

Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems

Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 834 · see citing works

Facing the Truth about Nanotechnology in Drug Delivery

Park, K. (2013) · ACS Nano · doi:10.1021/nn404501g · Cited by 545 · see citing works

Drug self-delivery systems for cancer therapy

Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532 · see citing works

Stability of nanosuspensions in drug delivery

Wang, Y., Zheng, Y., Zhang, L., Wang, Q., & Zhang, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.006 · Cited by 493 · see citing works

Nanodrugs: pharmacokinetics and safety

Onoue, S., Yamada, S., & Chan, H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s38378 · Cited by 383 · see citing works

Pharmaceutical nanocrystals: production by wet milling and applications

Malamatari, M., Taylor, K. M. G., Malamataris, S., Douroumis, D., & Kachrimanis, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.016 · Cited by 372 · see citing works

Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability

Gigliobianco, M. R., Casadidio, C., Censi, R., & Martino, P. D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030134 · Cited by 368 · see citing works

BCS class IV drugs: Highly notorious candidates for formulation development

Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 369 · see citing works

Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma

Chai, Z., Ran, D., Lu, L., Zhan, C., Ruan, H., Hu, X., Xie, C., Jiang, K., Li, J., Zhou, J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00661 · Cited by 359 · see citing works

Progress, challenges, and future of nanomedicine

Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 319 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review

Padrela, L., Rodrigues, M. Â., Duarte, A., Dias, A. M. A., Braga, M. E. M., & de Sousa, H. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.010 · Cited by 264 · see citing works

Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery

Pawar, V. K., Singh, Y., Meher, J. G., Gupta, S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.030 · Cited by 250 · see citing works

Current developments and applications of microfluidic technology toward clinical translation of nanomedicines

Liu, D., Zhang, H., Fontana, F., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.003 · Cited by 238 · see citing works

Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation

Ahmed, S., Kassem, M. A. A., & Sayed, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s278688 · Cited by 199 · see citing works

Injected nanocrystals for targeted drug delivery

Lü, Y., Li, Y., & Wu, W. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.11.005 · Cited by 191 · see citing works

Smart nanoparticles for drug delivery: Boundaries and opportunities

Lee, B. K., Yun, Y. H., & Park, K. (2014) · Chemical Engineering Science · doi:10.1016/j.ces.2014.06.042 · Cited by 188 · see citing works

Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles

Shekhawat, P. B., & Pokharkar, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.005 · Cited by 178 · see citing works

Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes

McGuckin, M. B., Wang, J., Ghanma, R., Qin, N., Palma, S. D., Donnelly, R. F., & Paredes, A. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.012 · Cited by 171 · see citing works

Clinically established biodegradable long acting injectables: An industry perspective

Nkanga, C. I., Fisch, A., Rad‐Malekshahi, M., Romić, M. D., Kittel, B., Ullrich, T., Wang, J., Krause, R. W. M., Adler, S., Lammers, T., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.008 · Cited by 168 · see citing works

Drug nanocrystals: Fabrication methods and promising therapeutic applications

Mohammad, I. S., Hu, H., Yin, L., & He, W. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.045 · Cited by 164 · see citing works

Nanocrystals: a perspective on translational research and clinical studies

Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162 · see citing works

Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine

Zhang, L. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1660732 · Cited by 162 · see citing works

Drug nanocrystals – Versatile option for formulation of poorly soluble materials

Peltonen, L., & Hirvonen, J. J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.005 · Cited by 157 · see citing works

Novel strategies for the formulation and processing of poorly water-soluble drugs

Göke, K., Lorenz, T., Repanas, A., Schneider, F., Steiner, D., Baumann, K., Bunjes, H., Dietzel, A. H., Finke, J. H., Glasmacher, B., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.008 · Cited by 156 · see citing works

Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications

Ahire, E. D., Thakkar, S., Darshanwad, M., & Misra, M. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.07.011 · Cited by 153 · see citing works

Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches

Witika, B. A., Makoni, P. A., Matafwali, S. K., Chabalenge, B., Mwila, C., Kalungia, A. C., Nkanga, C. I., Bapolisi, A. M., & Walker, R. B. (2020) · Nanomaterials · doi:10.3390/nano10091649 · Cited by 144 · see citing works

Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension

Ahuja, B. K., Jena, S. K., Paidi, S. K., Bagri, S., & Suresh, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.003 · Cited by 137 · see citing works

Developing Nanocrystals for Cancer Treatment

Lü, Y., Chen, Y., Gemeinhart, R. A., Wu, W., & Li, T. (2015) · Nanomedicine · doi:10.2217/nnm.15.73 · Cited by 135 · see citing works

Nanonization of curcumin by antisolvent precipitation: Process development, characterization, freeze drying and stability performance

Yadav, D., & Kumar, N. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.070 · Cited by 133 · see citing works

Self-Assembled Organic Nanomaterials for Drug Delivery, Bioimaging, and Cancer Therapy

Zhang, Y., Fang, F., Li, L., & Zhang, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00883 · Cited by 128 · see citing works

The in vivo fate of nanocrystals

Lü, Y., Qi, J., Dong, X., Zhao, W., & Wu, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.003 · Cited by 127 · see citing works

The formulation of nanomedicines for treating tuberculosis

Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works

Hybrid drug nanocrystals

Lü, Y., Lv, Y., & Li, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.006 · Cited by 117 · see citing works

Safety of nanosuspensions in drug delivery

Wang, L., Du, J., Zhou, Y., & Wang, Y. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.007 · Cited by 112 · see citing works

Solubility, Extraction, and Nanoparticles Production in Supercritical Carbon Dioxide: A Mini‐Review

Sodeifian, G., & Usefi, M. M. B. (2022) · ChemBioEng Reviews · doi:10.1002/cben.202200020 · Cited by 101 · see citing works

A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein

Pi, J., Wang, S., Wen, L., Kebebe, D., Zhang, Y., Zhang, B., Qi, D., Guo, P., Li, N., & Liu, Z. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.04.009 · Cited by 100 · see citing works

Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies

Haeri, A., Osouli, M., Bayat, F., Alavi, S., & Dadashzadeh, S. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1408123 · Cited by 93 · see citing works

State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation

Couillaud, B. M., Espeau, P., Mignet, N., & Corvis, Y. (2018) · ChemMedChem · doi:10.1002/cmdc.201800612 · Cited by 93 · see citing works

Formulation and drying of miconazole and itraconazole nanosuspensions

Cerdeira, A. M., Mazzotti, M., & Gander, B. A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.044 · Cited by 93 · see citing works

Nanocrystal Preparation: Low-Energy Precipitation Method Revisited

Khan, S., de Matas, M., Zhang, J., & Anwar, J. (2013) · Crystal Growth & Design · doi:10.1021/cg4000473 · Cited by 88 · see citing works

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds

Nie, X., Chen, Z., Pang, L., Wang, L., Jiang, H., Chen, Y., Zhang, Z., Fu, C., Ren, B., & Zhang, J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s285134 · Cited by 86 · see citing works

Recent Advances for Improving Functionality, Biocompatibility, and Longevity of Implantable Medical Devices and Deliverable Drug Delivery Systems

Kutner, N., Kunduru, K. R., Rizik, L., & Farah, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010929 · Cited by 81 · see citing works

Nanocrystals based pulmonary inhalation delivery system: advance and challenge

Yue, P., Zhou, W., Huang, G. S., Lei, F., Chen, Y., Ma, Z., Chen, L., & Yang, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2039809 · Cited by 81 · see citing works

Nanotechnology development in surgical applications: recent trends and developments

Abaszadeh, F., Ashoub, M. H., Khajouie, G., & Amiri, M. (2023) · European journal of medical research · doi:10.1186/s40001-023-01429-4 · Cited by 91 · see citing works

Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach

Karaküçük, A., Çelebi, N., & Teksin, Z. Ş. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.010 · Cited by 79 · see citing works

Biodegradable Cyclomatrix Polyphosphazene Nanoparticles: A Novel pH-Responsive Drug Self-Framed Delivery System

Hou, S., Chen, S., Dong, Y., Gao, S., Zhu, B., & Lu, Q. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b06114 · Cited by 79 · see citing works

Bexarotene nanocrystal—Oral and parenteral formulation development, characterization and pharmacokinetic evaluation

Chen, L., Wang, Y., Zhang, J., Hao, L., Guo, H., Lou, H., & Zhang, D. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.005 · Cited by 78 · see citing works

Mechanisms for oral absorption enhancement of drugs by nanocrystals

Liu, J., Tu, L., Cheng, M., Feng, J., & Jin, Y. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101607 · Cited by 78 · see citing works

Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy

Wang, J., Muhammad, N., Li, T., Wang, H., Liu, Y., Liu, B., & Zhan, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00161 · Cited by 79 · see citing works

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques

Jacob, S., Kather, F. S., Boddu, S. H. S., Attimarad, M., & Nair, A. B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010136 · Cited by 77 · see citing works

Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size

Leng, D., Chen, H., Li, G., Guo, M., Zhu, Z., Xu, L., & Wang, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.052 · Cited by 76 · see citing works

Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies

Xie, Y., Shi, B., Xia, F., Qi, J., Dong, X., Zhao, W., Li, T., Wu, W., & Lü, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.046 · Cited by 76 · see citing works

General considerations regarding the in vitro and in vivo properties of block copolymer micelle products and their evaluation

Sakai-Kato, K., Nishiyama, N., Kozaki, M., Nakanishi, T., Matsuda, Y., Hirano, M., Hanada, H., Hisada, S., Onodera, H., Harashima, H., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.259 · Cited by 75 · see citing works

Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug

Paredes, A. J., Camacho, N. M., Schofs, L., Dib, A., Zarazaga, M. D. P., Litterio, N. J., Allemandi, D. A., Bruni, S. F. S., Lanusse, C., & Palma, S. D. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119501 · Cited by 75 · see citing works

Nanoscale Delivery System for Nutraceuticals: Preparation, Application, Characterization, Safety, and Future Trends

Chen, J., & Hu, L. (2019) · Food Engineering Reviews · doi:10.1007/s12393-019-09208-w · Cited by 74 · see citing works

A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies

Karashima, M., Kimoto, K., Yamamoto, K., Kojima, T., & Ikeda, Y. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.006 · Cited by 73 · see citing works

Nanoparticles in Medicine: Current Status in Cancer Treatment

Pavelić, K., Pavelić, S. K., Bulog, A., Agaj, A., Rojnić, B., Čolić, M., & Trivanović, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612827 · Cited by 71 · see citing works

Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson’s Disease

Chen, T., Li, C., Li, Y., Yi, X., Lee, S. M., & Zheng, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00644 · Cited by 70 · see citing works

Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential

Sharma, M., & Mehta, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-52645-0 · Cited by 70 · see citing works

Targeting of Injectable Drug Nanocrystals

Fuhrmann, K., Gauthier, M. A., & Leroux, J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5001247 · Cited by 69 · see citing works

Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases

Bairagi, R. D., Reon, R. R., Hasan, M. M., Sarker, S. K., Debnath, D., Rahman, M. T., Rahman, S., Islam, M. A., Siddique, M. A. T., Bokshi, B., et al. (2025) · Discover Nano · doi:10.1186/s11671-025-04234-6 · Cited by 69 · see citing works

Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery

Shen, C., Yang, Y., Shen, B., Xie, Y., Qi, J., Dong, X., Zhao, W., Zhu, W., Wu, W., Yuan, H., et al. (2017) · Nanoscale · doi:10.1039/c7nr06052a · Cited by 68 · see citing works

Soluplus® as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features

Attia, M. S., Elshahat, A., Hamdy, A., Fathi, A. M., Emad-Eldin, M., Ghazy, F.-E. S., Chopra, H., & Ibrahim, T. M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104519 · Cited by 67 · see citing works

A novel electrospun nanofiber system with PEGylated paclitaxel nanocrystals enhancing the transmucus permeability and in situ retention for an efficient cervicovaginal cancer therapy

Duan, H., Chen, H., Qi, C., Lv, F.-M., Wang, J., Liu, Y., Liu, Z., & Liu, Y. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123660 · Cited by 66 · see citing works

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment

Asefy, Z., Hoseinnejhad, S., & Ceferov, Z. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05234-x · Cited by 64 · see citing works

Facile Engineering of Indomethacin-Induced Paclitaxel Nanocrystal Aggregates as Carrier-Free Nanomedicine with Improved Synergetic Antitumor Activity

Zhang, C., Long, L., Xiong, Y., Wang, C., Peng, C., Yuan, Y., Liu, Z.-R., Lin, Y., Jia, Y., Zhou, X. W., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b22336 · Cited by 61 · see citing works

Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics

Shen, Y., Gwak, H., & Han, B. (2023) · The Analyst · doi:10.1039/d3an01739g · Cited by 61 · see citing works

A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis

Mohammad, I. S., He, W., & Yin, L. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2370-0 · Cited by 60 · see citing works

The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin

Shen, B., Shen, C., Zhu, W., & Yuan, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.015 · Cited by 59 · see citing works

A Nano‐in‐Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals

Liu, D., Bernuz, C. R., Fan, J., Li, W., Correia, A., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604508 · Cited by 58 · see citing works

Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics

Mascarenhas, M., Chaudhari, P., & Lewis, S. A. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02541-x · Cited by 57 · see citing works

Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Etodolac

Afifi, S. A., Hassan, M. A., Abdelhameed, A. S., & Elkhodairy, K. A. (2015) · International Journal of Polymer Science · doi:10.1155/2015/938594 · Cited by 57 · see citing works

Green Mass Production of Pure Nanodrugs via an Ice-Template-Assisted Strategy

Zhang, J., Nie, W., Chen, R., Chelora, J., Wan, Y., Cui, X., Zhang, X., Zhang, W., Chen, X., Xie, H., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03043 · Cited by 57 · see citing works

Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling

Lv, Y., Wu, W., Corpstein, C. D., Li, T., & Lü, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114466 · Cited by 56 · see citing works

Gemcitabine–camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics

Hou, M., Xue, P., Gao, Y.-E., Ma, X., Bai, S., Kang, Y., & Xu, Z. (2017) · Biomaterials Science · doi:10.1039/c7bm00382j · Cited by 56 · see citing works

Novel nanocrystal-based formulations of apremilast for improved topical delivery

Parmar, P. K., & Bansal, A. K. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00809-1 · Cited by 56 · see citing works

Tacrolimus nanocrystals microneedle patch for plaque psoriasis

Men, Z., Su, T., Tang, Z., Liang, J., & Shen, T. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122207 · Cited by 55 · see citing works

Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods

Tian, Y., Wang, S., Yu, Y., Sun, W., Fan, R., Shi, J., Gu, W., Wang, Z., Zhang, H., & Zheng, A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121862 · Cited by 54 · see citing works

Advances of Combinative Nanocrystal Preparation Technology for Improving the Insoluble Drug Solubility and Bioavailability

Ran, Q., Wang, M., Kuang, W., Ouyang, J., Han, D., Gao, Z., & Gong, J. (2022) · Crystals · doi:10.3390/cryst12091200 · Cited by 54 · see citing works

Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box–Behnken Design

Kassem, M. A., ElMeshad, A. N., & Fares, A. R. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0604-1 · Cited by 58 · see citing works

Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations

Leone, F., & Cavalli, R. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1043886 · Cited by 53 · see citing works

Oral nanomedicine approaches for the treatment of psychiatric illnesses

Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.047 · Cited by 53 · see citing works

Directed self-assembly of fluorescence responsive nanoparticles and their use for real-time surface and cellular imaging

Cheung, S., & O’Shea, D. F. (2017) · Nature Communications · doi:10.1038/s41467-017-02060-8 · Cited by 53 · see citing works

Oral Bioavailability and Pharmacodynamic Activity of Hesperetin Nanocrystals Generated Using a Novel Bottom-up Technology

Shete, G., Pawar, Y. B., Thanki, K., Jain, S., & Bansal, A. K. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5008647 · Cited by 52 · see citing works

The Role of Particle Size in Drug Release and Absorption

Sandri, G., Bonferoni, M. C., Ferrari, F., Rossi, S., & Caramella, C. M. (2013) · Particle technology series · doi:10.1007/978-3-319-00714-4_11 · Cited by 52 · see citing works

Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges

Kaialy, W., & Shafiee, M. A. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.11.010 · Cited by 51 · see citing works

Nanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases

Fathi‐karkan, S., Ramsheh, N. A., Arkaban, H., Narooie-Noori, F., Sargazi, S., Mirinejad, S., Roostaee, M., Sargazi, S., Barani, M., Shadman, S. M., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124226 · Cited by 48 · see citing works

Ultra Rapidly Dissolving Repaglinide Nanosized Crystals Prepared via Bottom-Up and Top-Down Approach: Influence of Food on Pharmacokinetics Behavior

Gadadare, R., Mandpe, L., & Pokharkar, V. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0267-8 · Cited by 46 · see citing works

Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium

Xia, D., He, Y., Li, Q., Hu, C., Huang, W., Zhang, Y., Wan, F., Wang, C., & Gan, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.012 · Cited by 46 · see citing works

Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice

Pensel, P. E., Paredes, A. J., Albani, C. M., Allemandi, D. A., Bruni, S. F. S., Palma, S. D., & Elissondo, M. C. (2017) · Veterinary Parasitology · doi:10.1016/j.vetpar.2017.12.022 · Cited by 46 · see citing works

Controlled formation and stabilization of nanosized colloidal suspensions by combination of soy protein and biosurfactant stevioside as stabilizers

Wan, Z.-L., Wang, L., Yang, X., Wang, J., & Wang, L. (2015) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2015.07.005 · Cited by 45 · see citing works

A comparative study of thermo-sensitive hydrogels with water-insoluble paclitaxel in molecule, nanocrystal and microcrystal dispersions

Lin, Z., Mei, D., Chen, M., Wang, Y., Chen, X., Wang, Z., He, B., Zhang, H., Wang, X., Dai, W., et al. (2015) · Nanoscale · doi:10.1039/c5nr03623b · Cited by 45 · see citing works

A novel nanosuspension of andrographolide: Preparation, characterization and passive liver target evaluation in rats

Guo, L., Kang, L., Liu, X., Lin, X., Di, D., Wu, Y., Kong, D., Deng, Y., & Song, Y. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.017 · Cited by 45 · see citing works

Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements

Kuroiwa, Y., Higashi, K., Ueda, K., Yamamoto, K., & Moribe, K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.028 · Cited by 44 · see citing works

Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by Eudragit E100

Fan, N., Ma, P., Wang, X., Li, C., Zhang, X., Zhang, K., Li, J., & He, Z. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.07.036 · Cited by 44 · see citing works

Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions

Zhao, Z., Katai, H., Higashi, K., Ueda, K., Kawakami, K., & Moribe, K. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00158 · Cited by 44 · see citing works

Fabrication of Fine Puerarin Nanocrystals by Box–Behnken Design to Enhance Intestinal Absorption

Cheng, M., Yuan, F., Liu, J., Liu, W., Feng, J., Jin, Y., & Tu, L. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1616-4 · Cited by 44 · see citing works

Stabilizers used in nano-crystal based drug delivery systems

Shete, G., Jain, H., Punj, D., Prajapat, H., Akotiya, P., & Bansal, A. K. (2016) · International Journal of Pharmaceutical Excipients · doi:10.66617/001c.941 · Cited by 43 · see citing works

Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions

Li, W., Quan, P., Zhang, Y., Cheng, J., Liu, J., Cun, D., Xiang, R., & Fang, L. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.038 · Cited by 43 · see citing works

Production, applications and in vivo fate of drug nanocrystals

Tuomela, A., Saarinen, J. K. S., Strachan, C. J., Hirvonen, J. J., & Peltonen, L. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.02.006 · Cited by 41 · see citing works

Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs

Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L. F., Li, X., & Wang, F. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0889-z · Cited by 227 · see citing works

Analytical tools for reliable in vitro and in vivo performance testing of drug nanocrystals

Tuomela, A., Saarinen, J. K. S., Hirvonen, J. J., & Peltonen, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813629-4.00011-5 · Cited by 2 · see citing works

Drug nanocrystals in drug delivery andpharmacokinetics

Chiarappa, G. (2018) · Cited by 2 · see citing works

A Review On Nanocrystals In Drug Delivery

Sase, S. M., Merekar, A. N., Dokhe, M. D., & Parjane, S. (2020) · American Journal of PharmTech Research · doi:10.46624/ajptr.2020.v10.i2.008 · Cited by 2 · see citing works